Thompson, P., Tadmor, T., Bentzen, H. H., Córdoba, R., Snauwaert, S., Goldschmidt, N., Simkovic, M., Christensen, J., Jimenez, J. L., Benjamini, O., Oki, T., Steele, A. J., Mørch, M. H., Tucker, E., Valentin, R., Danilov, A., Vitolo, U. (2025). Epcoritamab combinations demonstrate promising efficacy in patients (pts) with Richter transformation (RT): First results from arms 2B (epcor + lenalidomide [LEN]) and 2C (epcor + R-CHOP) of the phase 1b/2 EPCORE CLL-1 trial. Blood. https://doi.org/10.1182/blood-2025-1015